Laboratory Corporation of America Holdings

Labcorp helps patients, providers, organizations, and biopharma companies to guide vital healthcare decisions each and every day.

From the manufacturer's own website. Source

The company develops and provides in vitro diagnostic (IVD) assays and genetic tests, including immune profiling assays, genomic profiling tests, lipid panel assays, and APOL1 genotyping tests. These products are designed for clinical use in assessing genetic predispositions, immune responses, and biomarkers related to cardiovascular and genetic conditions. Additional offerings include neutralizing antibody assays for adeno-associated virus (AAV) vectors, used in gene therapy research and development. The company also provides a comprehensive oncology-focused LDT assay for detecting genetic mutations in cancer patients.

The portfolio includes devices classified under Class I and IVD General categories, with regulatory listings in the EU’s eudamed database and the FDA’s 510(k) clearance registry. These devices are intended for use in laboratory settings and are governed by applicable IVD regulations in the United States and European Union. The company operates primarily from its headquarters in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.